Cargando…
Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
Cytogenetic alterations form the basis for risk stratification for multiple myeloma (MM) and guide the selection of therapy; however, current pathology assays performed on bone marrow samples can produce false‐negatives due to the unpredictable distribution and rarity of MM cells. Here, we report on...
Autores principales: | Zeng, Yunjing, Gao, Li, Luo, Xiaoqing, Chen, Yan, Kabeer, Mustafa H., Chen, Xuelian, Stucky, Andres, Loudon, William G., Li, Shengwen C., Zhang, Xi, Zhong, Jiang F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026869/ https://www.ncbi.nlm.nih.gov/pubmed/29638042 http://dx.doi.org/10.1002/1878-0261.12201 |
Ejemplares similares
-
Corrigendum to: Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
por: Zeng, Yunjing, et al.
Publicado: (2021) -
Single-cell transcriptomes reveal the mechanism for a breast cancer prognostic gene panel
por: Li, Shengwen Calvin, et al.
Publicado: (2018) -
Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes
por: Stucky, Andres, et al.
Publicado: (2022) -
RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression
Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for
Pediatric Neuroblastoma
por: Sun, Lan, et al.
Publicado: (2023) -
BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study
por: Li, Xiaoqing, et al.
Publicado: (2021)